Top Wall Street analysts changed their outlook on these top names.
For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
Leerink Partners analyst Jonathan Chang upgraded Replimune Group Inc (NASDAQ:REPL) from Market Perform to Outperform and raised the price target from $11 to $17.
Replimune Group closed at $11.91 on Monday.
See how other analysts view this stock.







